TickerFactsScreenerDevelopers

ImmunityBio, Inc. (IBRX) — Net Income

Annual figures by fiscal year, from SEC filings.

2013: -$2.05M2014: -$6.18M2015: -$236.88M2016: -$120.81M2017: -$96.42M2018: -$96.23M2019: -$157.78M2020: -$221.85M2021: -$346.79M2022: -$416.57M2023: -$583.20M2024: -$413.56M2025: -$351.40M-$351.40M
2013Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$351.40M+15.0%
2024-$413.56M+29.1%
2023-$583.20M-40.0%
2022-$416.57M-20.1%
2021-$346.79M-56.3%
2020-$221.85M-40.6%
2019-$157.78M-64.0%
2018-$96.23M+0.2%
2017-$96.42M+20.2%
2016-$120.81M+49.0%
2015-$236.88M-3729.8%
2014-$6.18M-202.1%
2013-$2.05M—